Country: যুক্তরাজ্য
ভাষা: ইংরেজি
সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)
Dexamethasone
DE Pharmaceuticals
H02AB02
Dexamethasone
4mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06030200
PACKAGE LEAFLET: INFORMATION FOR THE USER DECADRON ® 4MG TABLETS (DEXAMETHASONE) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. • The name of your medicine is Decadron ® 4mg tablets but will be referred to as Decadron throughout the remainder of this leaflet. • Decadron is also available in other strengths. WHAT IS IN THIS LEAFLET 1. What Decadron is and what it is used for 2. What you need to know before you take Decadron 3. How to take Decadron 4. Possible side effects 5. How to store Decadron 6. Contents of the pack and other information 1. WHAT DECADRON IS AND WHAT IT IS USED FOR Decadron is a synthetic glucocorticoid. Glucocorticoids are hormones produced by the cortex of adrenal glands. The medicine has anti-inflammatory, analgesic and anti-allergic effects, and suppresses the immune system. Decadron is recommended for the treatment of rheumatic and autoimmune diseases (e.g. systemic lupus erythematosus, rheumatoid arthritis, juvenile idiopathic arthritis, polyarthritis nodosa), diseases of respiratory tract (e.g. bronchial asthma, croup), skin (e.g. erythroderma, pemphigus vulgaris), tuberculous meningitis only in conjunction with anti-infective therapy, diseases of blood (e.g. idiopathic thrombocytopenic purpura in adults), cerebral oedema, treatment of symptomatic multiple myeloma, acute lymphoblastic leukemia, Hodgkin’s disease and non-Hodgkin’s lymphoma in combination with other medicinal products, palliative treatment of neoplastic diseases, prophylaxis and treatment of nausea and vomiting caused সম্পূর্ণ নথি পড়ুন
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dexamethasone 4 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 4 mg of Dexamethasone. Excipient with known effect Each tablet contains approximately 141 mg Lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Each tablet contains 4 mg of Dexamethasone. Excipient with known effect Each tablet contains approximately 141 mg Lactose monohydrate. For the full list of excipients, see section 6.1. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS NEUROLOGY Cerebral oedema (only with symptoms of intracranial pressure evidenced by computerised tomography) caused by a brain tumour, neuro-surgical intervention, cerebral abscess. PULMONARY AND RESPIRATORY DISEASES Acute asthma exacerbations when use of an oral corticosteroid (OCS) is appropriate, croup. DERMATOLOGY Initial treatment of extensive, severe, acute, skin diseases responding to glucocorticoids, e.g. erythroderma, pemphigus vulgaris. AUTOIMMUNE DISORDERS/RHEUMATOLOGY Initial treatment of autoimmune disorders like systemic lupus erythematodes. Active phases of systemic vasculitides like panarteritis nodosa (treatment duration should be limited to two weeks in cases of concomitant positive hepatitis B serology). Severe progressive course of active rheumatoid arthritis, e.g. fast proceeding destructive forms and/or extraarticular manifestations. Severe systemic course of juvenile idiopathic arthritis (Still's disease). HAEMATOLOGICAL DISORDER Idiopathic thrombocytopenic purpura in adults. INFECTOLOGY Tuberculous meningitis only in conjunction with anti-infective therapy. ONCOLOGY Palliative treatment of neoplastic diseases. Prophylaxis and treatment of emesis induced by cytostatics, emetogenic chemotherapy within antiemetic treatment. Treatment of symptomatic multiple myeloma, acute lymphoblastic leukemia, Hodgkin's disease and non-Hodgkin's lymphoma in combination with other medicinal products. VARIOUS Prevention and treatment of pos সম্পূর্ণ নথি পড়ুন